title: Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
authors.affiliation: Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Eric
authors.initials: E
authors.lastname: Black-Maier
authors.affiliation: Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina, USA.|Duke Clinical Research Institute, Durham, North Carolina, USA.
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Piccini
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants; D001281:Atrial Fibrillation; D001777:Blood Coagulation / Q000187:drug effects; D006801:Humans; D007676:Kidney Failure, Chronic; D020521:Stroke; D015912:Thrombolytic Therapy
chemical_list: D000925:Anticoagulants